Abstract
STA Pharmaceutical, the active pharmaceutical ingredient (API) manufacturing arm of WuXi AppTec, has opened a large-scale oligonucleotide API plant in Changzhou, China. The 2,800 m2 facility is designed to make up to 1 mol per synthesis run. STA says its oligo platform covers modalities including DNA, RNA, Morpholino oligonucleotides, and peptide conjugates.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
